PEPT (SLC15A) Family

Pharmacogenomics of Human Drug Transporters: Clinical Impacts

Volumn , Issue , 2013, Pages 223-242

  Sugiura, Tomoko ^a   Umeda, Saki ^a   Tsuji, Akira ^a   Kato, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Brain; Drug disposition; Kidney; PDZ adaptor; PEPT1; PEPT2; Small intestine; Tumor

Indexed keywords

EID: 84886181340     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118353240.ch10     Document Type: Chapter

References (88)

1. Adibi SA (2003) Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am J Physiol Gastrointest Liver Physiol, 285, G779-G788.
2. Adibi SA, KrzysikBA (1977) Effect of nephrectomy and enterectomy on plasma clearance of intravenously administered dipeptides in rats. Clin Sci Mol Med, 52, 205-213.
3. Adibi SA, Krzysik BA, Drash AL (1977) Metabolism of intravenously administered dipeptides in rats: effects on amino acid pools, glucose concentration, and insulin and glucagon secretion. Clin Sci Mol Med, 52, 193-204.
4. Anderle P, Nielsen CU, Pinsonneault J, Krog PL, Brodin B, SadéeW (2006) Genetic variants of the human dipeptide transporter PEPT1. J Pharmacol Exp Ther, 316, 636-646.
5. Bahadduri PM, D'Souza VM, Pinsonneault JK, Sadée W, Bao S, Knoell DL, Swaan PW (2005) Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium. Am J Respir Cell Mol Biol, 32, 319-325.
6. Balimane PV, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach FH, Tsuji A, Sinko PJ (1998) Direct evidence for peptide transporter (PepT1) -mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun, 250, 246-251.
7. Berger UV, Hediger MA (1999) Distribution of peptide transporter PEPT2 mRNA in the rat nervous system. Anat Embryol (Berl) , 199, 439-449.
8. Bhardwaj RK, Herrera-Ruiz D, Eltoukhy N, Saad M, Knipp GT (2006) The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells. Eur J Pharm Sci, 27, 533-542.
9. Biegel A, Knütter I, Hartrodt B, Gebauer S, Theis S, Luckner P, Kottra G, Rastetter M, Zebisch K, Thondorf I, et al. (2006) The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino Acids, 31, 137-156.
10. Buyse M, Charrier L, Sitaraman S, Gewirtz A, Merlin D (2003) Interferon-gamma increases hPepT1- mediated uptake of di-tripeptides including the bacterial tripeptide fMLP in polarized intestinal epithelia. Am J Pathol, 163, 1969-1977.
11. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D (2008) PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134, 166-178.
12. Daniel H, Kottra G (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch, 447, 610-618.
13. Döring F, Walter J, Will J, Föcking M, Boll M, Amasheh S, Clauss W, Daniel H (1998) Deltaaminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Invest, 101, 2761-2767.
14. Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, Singh SK, Boron WF, Hediger MA (1994) Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature, 368, 563-566.
15. Fei YJ, Liu W, Prasad PD, Kekuda R, Oblak TG, Ganapathy V, Leibach FH (1997) Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2. Biochemistry, 36, 452-460.
16. Frey IM, Rubio-Aliaga I, Klempt M, Wolf E, Daniel H (2006) Phenotype analysis of mice deficient in the peptide transporter PEPT2 in response to alterations in dietary protein intake. Pflugers Arch, 452, 300-306.
17. Frey IM, Rubio-Aliaga I, Siewert A, Sailer D, Drobyshev A, Beckers J, de Angelis MH, Aubert J, Bar Hen A, Fiehn O, et al. (2007) Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice. Physiol Genomics, 28, 301-310.
18. Ganapathy V, Leibach FH (1982) Peptide transport in rabbit kidney. Studies with L-carnosine. Biochim Biophys Acta, 691, 362-366.
19. Ganapathy V, Leibach FH (1983) Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit. Studies with L-carnosine and glycyl-L-proline. J Biol Chem, 258, 14189-14192.
20. Gonzalez DE, Covitz KM, Sadée W, Mrsny RJ (1998) An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Cancer Res, 58, 519-525.
21. Groneberg DA, Eynott PR, Döring F, Dinh QT, Oates T, Barnes PJ, Chung KF, Daniel H, Fischer A (2002) Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung. Thorax, 57, 55-60.
22. Groneberg DA, Nickolaus M, Springer J, Döring F, Daniel H, Fischer A (2001) Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am J Pathol, 158, 707-714.
23. He CF, Liu YS, Cheng YL, Gao JP, Pan TM, Han JW, Quan C, Sun LD, Zheng HF, Zuo XB, et al. (2010) TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus, 19, 1181-1186.
24. Herrera-Ruiz D, Wang Q, Gudmundsson OS, Cook TJ, Smith RL, Faria TN, Knipp GT (2001) Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues. AAPS Pharm Sci, 3, E9.
25. Hu Y, Smith DE, Ma K, Jappar D, Thomas W, Hillgren KM (2008) Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. Mol Pharm, 5, 1122-1130.
26. Jiang H, Hu Y, Keep RF, Smith DE (2009) Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice. J Neurochem, 109, 1536-1563.
27. Kamal MA, Jiang H, Hu Y, Keep RF, Smith DE (2009) Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice. Am J Physiol Regul Integr Comp Physiol, 296, R986-R991.
28. Kamal MA, Keep RF, Smith DE (2008) Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab Pharmacokinet, 23, 236-242.
29. Kato Y, Yoshida K, Watanabe C, Sai Y, Tsuji A (2004) Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm Res, 21, 1886-1894.
30. Klapper M, Daniel H, Doring F (2006) Cytosolic COOH terminus of the peptide transporter PEPT2 is involved in apical membrane localization of the protein. Am J Physiol, 290, C472-C483.
31. Knütter I, Rubio-Aliaga I, Boll M, Hause G, Daniel H, Neubert K, Brandsch M (2002) H+-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1. Am J Physiol Gastrointest Liver Physiol, 283, G222-G229.
32. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñez G, Flavell RA (2005) Nod2- dependent regulation of innate and adaptive immunity in the intestinal tract. Science, 307, 731-734.
33. Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, Leibach FH (1995) Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem, 270, 6456-6463.
34. Liu R, Tang AM, Tan YL, Limenta LM, Lee EJ (2009) Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects. Eur J Clin Pharmacol, 65, 65-70.
35. Liu R, Tang AM, Tan YL, Limenta LM, Lee EJ (2011) Effects of sodium bicarbonate and ammonium chloride pre-treatments on the PEPT2 (SLC15A2) mediated renal clearance of cephalexin in healthy subjects. Drug Metab Pharmacokinet, 26, 87-93.
36. Liu W, Liang R, Ramamoorthy S, Fei YJ, Ganapathy ME, Hediger MA, Ganapathy V, Leibach FH (1995) Molecular cloning of PEPT2, a new member of the H+/peptide cotransporter family, from human kidney. Biochim Biophys Acta, 1235, 461-466.
37. Ma K, Hu Y, Smith DE (2010) Peptide transporter 1 is responsible for intestinal uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from wild-type and pept1 null mice. J Pharm Sci, 100, 767-774.
38. Merlin D, Si-Tahar M, Sitaraman SV, Eastburn K, Williams I, Liu X, Hediger MA, Madara JL (2001) Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules. Gastroenterology, 120, 1666-1679.
39. Mitsuoka K, Kato Y, Miyoshi S, Murakami Y, Hiraiwa M, Kubo Y, Nishimura S, Tsuji A (2010) Inhibition of oligopeptide transporter suppress growth of human pancreatic cancer cells. Eur J Pharm Sci, 40, 202-208.
40. Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A (2008) Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter. J Nucl Med, 49, 615-622.
41. Nabulsi NB, Smith DE, Kilbourn MR (2005) [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PEPT2 transporter function in kidney of PEPT2 null and wild-type mice. Bioorg Med Chem, 13, 2003-3001.
42. Nakanishi T, Tamai I, Sai Y, Sasaki T, Tsuji A (1997) Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080. Cancer Res, 57, 4118-4122.
43. Nakanishi T, Tamai I, Takaki A, Tsuji A (2000) Cancer cell-targeted drug delivery utilizing oligopeptide transport activity. Int J Cancer, 88, 274-280.
44. Naruhashi K, Sai Y, Tamai I, Suzuki N, Tsuji A (2002) PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine. Pharm Res, 19, 1417-1423.
45. Noshiro R, Anzai N, Sakata T, Miyazaki H, Terada T, Shin HJ, He X, Miura D, Inui K, Kanai Y, Endou H (2006) The PDZ domain protein PDZK1 interacts with human peptide transporter PEPT2 and enhances its transport activity. Kidney Int, 70, 275-282.
46. Nozawa T, Toyobuku H, Kobayashi D, Kuruma K, Tsuji A, Tamai I (2003) Enhanced intestinal absorption of drugs by activation of peptide transporter PEPT1 using proton-releasing polymer. J Pharm Sci, 92, 2208-2216.
47. Nutzenadel W, Scriver CR (1976) Uptake and metabolism of beta-alanine and L-carnosine by rat tissues in vitro: role in nutrition. Am J Physiol, 230, 643-651.
48. Ocheltree SM, Shen H, Hu Y, Keep RF, Smith DE (2005) Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J Pharmacol Exp Ther, 315, 240-247.
49. Ogihara T, Kano T, Wagatsuma T, Wada S, Yabuuchi H, Enomoto S, Morimoto K, Shirasaka Y, Kobayashi S, Tamai I (2009) Oseltamivir (tamiflu) is a substrate of peptide transporter 1. Drug Metab Dispos, 37, 1676-1681.
50. Pan X, Terada T, Irie M, Saito H, Inui K (2002) Diurnal rhythm of H+-peptide cotransporter in rat small intestine. Am J Physiol Gastrointest Liver Physiol, 283, G57-G64.
51. Pan X, Terada T, Okuda M, Inui K (2003) Altered diurnal rhythm of intestinal peptide transporter by fasting and its effects on the pharmacokinetics of ceftibuten. J Pharmacol Exp Ther, 307, 626-632.
52. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo BJ (2003) Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrob Agents Chemother, 47, 2351-2353.
53. Pinsonneault J, Nielsen CU, Sadée W (2004) Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions. J Pharmacol Exp Ther, 311, 1088-1096.
54. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn's disease and implicates autophagy in disease pathogenesis. Nat Genet, 39, 596-604.
55. Rubio-Aliaga I, Frey I, Boll M, Groneberg DA, Eichinger HM, Balling R, Daniel H (2003) Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney. Mol Cell Biol, 23, 3247-3252.
56. Sai Y, Tamai I, Sumikawa H, Hayashi K, Nakanishi T, Amano O, Numata M, Iseki S, Tsuji A (1996) Immunolocalization and pharmacological relevance of oligopeptide transporter PEPT1 in intestinal absorption of ß-lactam antibiotics. FEBS Lett, 392, 25-29.
57. Saito H, Okuda M, Terada T, Sasaki S, Inui K (1995) Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. J Pharmacol Exp Ther, 275, 1631-1637.
58. Sakata K, Yamashita T, Maeda M, Moriyama Y, Shimada S, Tohyama M (2001) Cloning of a lymphatic peptide/histidine transporter. Biochem J, 15, 53-60.
59. Sala-Rabanal M, Loo DD, Hirayama BA, Turk E, Wright EM (2006a) Molecular interactions between dipeptides, drugs, and the human intestinal H+-oligopeptide cotransporter hPEPT1. J Physiol, 574, 149-166.
60. Sala-Rabanal M, Loo DD, Hirayama BA, Wright EM (2006b) Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2. Am J Physiol Renal Physiol, 294, F1422-F1432.
61. Sato T, Mushiake S, Kato Y, Sato K, Sato M, Takeda N, Ozono K, Miki K, Kubo Y, Tsuji A, Harada R, Harada A (2007) The Rab8 GTPase regulates apical protein localization in intestinal cells. Nature, 448, 366-369.
62. Shen H, Ocheltree SM, Hu Y, Keep RF, Smith DE (2007) Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos, 35, 1209-1216.
63. Shen H, Smith DE, Keep RF, Brosius FC 3rd (2004) Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol Pharm, 1, 248-256.
64. Shen H, Smith DE, Keep RF, Xiang J, Brosius FC 3rd (2003) Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J Biol Chem, 278, 4786-4791.
65. Shen H, Smith DE, Yang T, Huang YG, Schnermann B, and Brosius FC (1999) Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol Renal Physiol, 276, F658-F665.
66. Shu C, Shen H, Teuscher NS, Lorenzi PJ, Keep RF, Smith DE (2002) Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. J Pharmacol Exp Ther, 301, 820-829.
67. Smith DE, Hu Y, Shen H, Nagaraja TN, Fenstermacher JD, Keep RF (2010) Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice. J Cereb Blood Flow Metab, 31, 250-261.
68. Sobin C, Gutierrez M, Alterio H (2009) Polymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure. Neurotoxicology, 30, 881-887.
69. Sugiura T, Kato Y, Kubo Y, TsujiA (2006) Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2. Drug Metab Pharmacokinet, 21, 375-383.
70. Sugiura T, Kato Y, Wakayama T, Silver DL, Kubo Y, Iseki S, Tsuji A (2008) PDZK1 regulates two intestinal solute carriers (SLC15A1 and SLC22A5) in mice. Drug Metab Dispos, 36, 1181-1188.
71. Swaan PW, Bensman T, Bahadduri PM, Hall MW, Sarkar A, Bao S, Khantwal CM, Ekins S, Knoell DL (2008) Bacterial peptide recognition and immune activation facilitated by human peptide transporter PEPT2. Am J Respir Cell Mol Biol, 39, 536-542.
72. Takeuchi F, Ochiai Y, Serizawa M, Yanai K, Kuzuya N, Kajio H, Honjo S, Takeda N, Kaburagi Y, Yasuda K, et al. (2008) Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q, and 12q. J Hum Genet, 53, 314-324.
73. Tamai I, Nakanishi T, Hayashi K, Terao T, Sai Y, Shiraga T, Miyamoto K, Takeda E, Higashida H, Tsuji A (1997) The predominant contribution of oligopeptide transporter PEPT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine. J Pharm Pharmacol, 49, 796-801.
74. Tamai I, Nakanishi T, Nakahara H, Sai Y, Ganapathy V, Leibach FH, Tsuji A (1998) Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PEPT1. J Pharm Sci, 87, 1542-1546.
75. Tamai I, Tomizawa N, Takeuchi T, Nakayama K, Higashida H, Tsuji A (1995) Functional expression of transporter for beta-lactam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestines. J Pharmacol Exp Ther, 273, 26-31.
76. Terada T, Irie M, Okuda M, Inui K (2004) Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function. Biochem Biophys Res Commun, 316, 416-420.
77. Terada T, Shimada Y, Pan X, Kishimoto K, Sakurai T, Doi R, Onodera H, Katsura T, Imamura M, Inui K (2005) Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract. Biochem Pharmacol, 70, 1756-1763.
78. Thwaites DT, Cavet M, Hirst BH, Simmons NL (1995) Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. Br J Pharmacol, 114, 981-986.
79. Tomita Y, Katsura T, Okano T, Inui K, Hori R (1990) Transport mechanisms of bestatin in rabbit intestinal brush-border membranes: role of H+/dipeptide cotransport system. J Pharmacol Exp Ther, 252, 859-862.
80. Tsuda M, Terada T, Irie M, Katsura T, Niida A, Tomita K, Fujii N, Inui K (2006) Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther, 318, 455-460.
81. Tsuji A (2002) Transporter-mediated drug interactions. Drug Metab Pharmacokinet, 17, 253-274.
82. Tsuji A, Nakashima E, Kagami I, Honjo N, Yamana T (1977) Effect of dose-concentration on the absorption of amoxicillin and ampicillin from the rat intestine. J Pharm Pharmcol, 29, 707-708.
83. Tsuji A, Tamai I, Nakanishi M, Amidon GL (1990) Mechanism of absorption of the dipeptide alphamethyldopa- phe in intestinal brush-border membrane vesicles. Pharm Res, 7, 308-309.
84. Xiang J, Jiang H, Hu Y, Smith DE, Keep RF (2010) Kyotorphin transport and metabolism in rat and mouse neonatal astrocytes. Brain Res, 1347, 11-18.
85. Yamashita T, Shimada S, Guo W, Sato K, Kohmura E, Hayakawa T, Takagi T, TohyamaM (1997) Cloning and functional expression of a brain peptide/histidine transporter. J Biol Chem, 272, 10205-10211.
86. Zhang EY, Fu DJ, Pak YA, Stewart T, Mukhopadhyay N, Wrighton SA, Hillgren KM (2004) Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586. J Pharmacol Exp Ther, 310, 437-445.
87. Zimmermann M, Stan AC (2010) PEPT2 transporter protein expression in human neoplastic glial cells and mediation of fluorescently tagged dipeptide derivative beta-Ala-Lys-Nepsilon-7-amino-4-methylcoumarin- 3-acetic acid accumulation. J Neurosurg, 112, 1005-1014.
88. Zucchelli M, Torkvist L, Bresso F, Halfvarson J, Hellquist A, Anedda F, Assadi G, Lindgren GB, Svanfeldt M, Janson M, et al. (2009) PEPT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease. Inflamm Bowel Dis, 15, 1562-1569.